Selective Phosphodiesterase Inhibitors in the Therapy of Asthma
- 1 June 1995
- journal article
- review article
- Published by Springer Nature in Clinical Immunotherapeutics
- Vol. 3 (6) , 423-437
- https://doi.org/10.1007/bf03259062
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Bronchial Epithelial CellsClinical Immunotherapeutics, 1994
- Expression and regulation of human and rat phosphodiesterase type IV isogenesFEBS Letters, 1994
- Receptor‐mediated endocytosis of plasminogen activators and activator/inhibitor complexesFEBS Letters, 1994
- Effects of rolipram and CI-930 on IL-2 mRNA transcription in human Jurkat cellsInflammation Research, 1993
- β-adrenoceptors on smooth muscle, nerves and inflammatory cellsLife Sciences, 1993
- β-adrenergic receptors in the lung: An introductionLife Sciences, 1993
- High pressure liquid chromatography of cyclic nucleotide phosphodiesterase from purified human T-lymphocytesBiochemical and Biophysical Research Communications, 1989
- The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune responseImmunology Today, 1988
- Phosphodiesterase Inhibition by Ro 20-1724 Reduces Hyper-IgE Synthesis by Atopic Dermatitis Cells In VitroJournal of Investigative Dermatology, 1985
- Partial purification and characterization of adenosine- and guanosine-3',5'-monophosphate phosphodiesterases from human lung tissueBiochemistry, 1976